High tissue factor (CD142) expression identifies a poor-prognosis subgroup of esophageal and esophagogastric junction adenocarcinoma. [PDF]
Bedau T +5 more
europepmc +1 more source
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma. [PDF]
Kurokawa Y +9 more
europepmc +1 more source
Molecular characteristics of proximal and distal esophagogastric junction adenocarcinoma. [PDF]
Qin X +7 more
europepmc +1 more source
Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma. [PDF]
Ding TY +11 more
europepmc +1 more source
Spectral CT-based Nomogram for Noninvasive Assessment and Prognostic Prediction of MSI/dMMR in Esophagogastric Junction Adenocarcinoma. [PDF]
Wu Y +7 more
europepmc +1 more source
Screening of molecular biomarkers ASPN and LBH and construction of a prediction nomogram for the progression of esophagogastric junction adenocarcinoma. [PDF]
Chen Y +12 more
europepmc +1 more source
Beyond Pathological Complete Response: Long-term Outcomes in Esophageal and Esophagogastric Junction Adenocarcinoma After Multimodal Therapy-A Systematic Review and Individual Patient-Data Meta-Analysis. [PDF]
Risi L +8 more
europepmc +1 more source
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. [PDF]
Liu YQ +7 more
europepmc +1 more source
Navigating Diagnostic Challenges in Pseudoachalasia: A Case Study of Esophagogastric Junction Adenocarcinoma. [PDF]
Nguyen TH +8 more
europepmc +1 more source
Comparison of lymph node metastasis pattern from esophagogastric junction adenocarcinoma versus very low thoracic esophageal squamous cancer: a propensity-matched analysis. [PDF]
Ma Z, Chen C, Shang X, Yue J, Jiang H.
europepmc +1 more source

